Background
==========

The diagnostic yield of microarray comparative genomic hybridizations (array CGH) has already proven to exceed that of cytogenetic methods, except when it comes to balanced rearrangements. A consensus statement suggests that microarrays should be used as the first line of testing for developmental disorders of unknown cause \[[@B1]\]. However, as our previous study shows, approximately 80 % of patients with a developmental disorder of unknown cause (mental retardation and/or malformations and/or neurological disorders) remain undiagnosed even by array CGH analysis (44 K, 180 K, or 244 K) \[[@B2]\]. Thus, other methods are clearly needed to define the pathogenic mechanisms. It is plausible that small copy number variants (CNVs) may go undetected if the probe coverage is limited, as it may be in low-resolution arrays. By increasing the resolution, one would thus expect to detect increasingly smaller pathogenic CNVs.

The frequency of uniparental disomy (UPD) in newborns is reportedly \~0.029% \[[@B3]\]. Around 1,100 cases of whole chromosome UPD and some 120 reports on segmental UPD are described in the literature \[[@B4]\]. Some recessive diseases are expressed in children who have inherited the mutation form a single carrier parent \[[@B5]\]. The explanation for this is a meiotic or very early mitotic recombination event between parental homologous chromosomes causing segmental UPD of the genomic segment containing the mutation, and thereby causing a reduction to homozygosity.

As the market is flooded with new arrays, most having an increased resolution and a promise of ever higher detection rates, the question remains what the added value is of these ultra-high resolution arrays. To test this, we used an array with 1.8 million probes and an average resolution of 0.7Kb to analyze samples of 35 patients with developmental disorder of unknown cause, normal karyotype, and normal array CGH results by use of Agilent 44 K, 180 K, or 244 K platforms (Agilent Technologies, Santa Clara, CA, USA).

Methods
=======

Participants
------------

Patients with previous normal array CGH results were asked to participate in the project. All 35 patients were Finnish of origin and had mild to severe mental retardation, associated with dysmorphic features and/or congenital anomalies (Table [1](#T1){ref-type="table"}). In addition, 16 patients also had epilepsy. For diagnostic purposes patients had previously been analyzed by whole-genome array CGH (Human Genome CGH Microarray, Agilent Technologies, Santa Clara, CA); 20 using the 244 K platform, 8 using a 180 K platform, and 7 using a 44 K platform. Informed consent was given by all participating families. Blood samples were collected from all patients and their parents. Ethical permission for this project was given by the Ethics Review Board of Helsinki and Uusimaa Hospital District.

###### 

Clinical characteristics of patients studied

  **P. Nr.**   **Growth**                                            **Head and neck**                                               **Eyes and vision**                                                     **Ears and hearing**                   **Face**                                                                    **Cardiovascular**               **Genitourinary**                    **Skeletal and limb defects**                                                **Neurologic**                                                        **Other**
  ------------ ----------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------- -------------------------------------- --------------------------------------------------------------------------- -------------------------------- ------------------------------------ ---------------------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------
  1\.          Obesity                                                                                                               Astigmatism                                                                                                                                                                                                                                                      Postaxial polydactyly (one foot) Short meta-carpals V finger clino-dactyly   ID Hypotonia                                                          Bardet-Biedl suspected
  2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Severe DD No walk/crawl No speech Epilepsy Drooling                    
  3\.                                                                Dolicocephaly Narrow, prominent forehead Low, uneven hairline   Epichantal folds                                                                                                                                                                                                                                                                                                                              DD Abnormal pons                                                      Hemangiomas
  4\.          Short stature                                                                                                                                                                                                                        Low nasal bridge                                                                                             Horseshoe kidney Anal atresia        Small hands and feet                                                         ID                                                                    Balanced t(X;13)(q28;q12)
  5\.                                                                                                                                                                                                        Simple ears                            Thick and straight eyebrows Broad nasal bridge Long philtrum Retrognathia                                                                                                                                                      Autism ID Epilepsy                                                     
  6\.          Short stature                                         Microcephaly                                                    Blindness Optic nerve hypoplasia                                                                                                                                                                                                                                 Scoliosis                                                                    ID Epilepsy Severe hypotonia                                           
  7\.                                                                Hydrocephalus                                                                                                                                                                                                                                                                                                                                                                                                 Brain malformation Severe DD                                           
  8                                                                  Microcephaly                                                    Hypertelorism                                                                                                  Small nose Low nasal bridge Tented upper lip                                                                                                                                                                                   Severe DD Severe epilepsy                                             ATRX suspected
  9\.                                                                                                                                Severe optic atrophy Impaired vision                                                                                                                                                                                                                                                                                                          ID Epilepsy Cortical atrophy                                           
  10\.                                                                                                                               Mild hypertelorism                                                      Low-set ears                           Triangular face Small jaw High palate Thin upper lip                                                                                              Hyper-extensible joints                                                      ID Autistic features Intractable epilepsy                             Frax-dna, SCN1A, CLN8 4p-FISH normal
  11\.                                                                                                                               Upslanting palpebal fissures                                            Large earlobes                         Small jaw                                                                                                                                         Clubfoot                                                                     ID Autistic features Intractable epilepsy                              
  12\.                                                                                                                               Epichantic folds                                                        Large earlobes                         Flat face                                                                                                                                         Tapering fingers                                                             ID Autistic features ADHD                                             Balanced t(2;9)(q13q22.3) de novo
  13\.                                                               Macrocephaly                                                                                                                                                                                                                                                                                                                                                                                                  Severe ID Hypotonia Autism Epilepsy                                   Inv 2(p13p25) mat., DMPK mutation negative
  14\.                                                                                                                               Severe myopia Cataracta                                                                                        Synophrys Curved eyebrows Upturned pinched nose Big mouth Full lips         Atrial septum defect                                                                                                                               Severe DD Epilepsy                                                     
  15\.                                                               Microcephaly                                                    Impaired vision                                                                                                                                                                            Ventricular septum defect                                                                                                                          Epilepsy DD                                                            
  16\.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ID Beahvioural disturbances Autism                                    No malformation or dysmorphism
  17\.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ID DD                                                                  
  18\.         Growth retardation                                                                                                    Hypertelorism                                                                                                                                                                              Mild ventricular septum defect                                                                                                                     ID                                                                     
  19\. & 20.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       DD                                                                    No structural defects
  21                                                                 Microcephaly                                                    Strabismus                                                              Missing lobuli                         Small nose Low nasal bridge Smooth philtrum Thin lips                                                                                             Proximal thumbs Pes planus                                                   ID Intractable epilepsy Ataxia                                         
  22\.         Pre- and postnatal growth retardation                                                                                                                                                                                                Broad nasal root Short nose Bifid nasal tip                                                                  Cryptorchidism Hypoplastic scrotum   Scoliosis Syndactylies                                                       Slow motor development Hypotonia Expressive language disorder         Congenital contractures Dimples
  23\.                                                                                                                                                                                                                                              Mild dysmorphism                                                                                                                                                                                                               ID Epilepsy                                                            
  24\.                                                               Microcephaly                                                    Hypertelorism Epicanthic folds Disorder of visual cortex                Low-set and posteriorly rotated ears   Micrognathia Cleft palate                                                                                                                                                                                                      ID Epilepsy Hypoplastic cerebellar vermis                             Monozygotic twin, twin sister healthy
  25\.         Tall stature Advanced bone age                                                                                        Deep set eyes Hypotelorism Epicanthic folds Strabismus                                                         Short nose Anteverted nares Tented upper lip                                                                 Cryptorchidism                                                                                                    ID No speech Autism                                                   Glypican-3 and PHF6 mutation analyses negative
  26\.         Short stature                                                                                                                                                                                                                                                                                                                                                                                                                                                       ID Intractable epilepsy Tremor Myoclonias Distal spasticity            
  27\.         Small for Gestational Age                                                                                             Downslanting palpebral fissures Strabismus                                                                     Frontal bossing                                                                                                                                   Exostosis (familial) Broad hallux Overriding toes Scoliosis                  ID Epilepsy                                                           Inguinal hernia
  28\.                                                                                                                               Downslanting palpebral fissures                                         Hearing impairment                     Coarse hair Thick eyebrows Thick lips Malposition of teeth                  Hypertrophic cardiomyopathy                                           Hip dis-placement Long thin bones                                            Normal intelligence                                                    
  29\.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Epilepsy ID Alternating hemiplegia of childhood                        
  30\.         Small for gestational age Prematurity Short stature   Microcephaly                                                    Severe myopia Coloboma of papillae Optic atrophy Nystagmus Strabismus                                          High palate Gum hypertrophy                                                 Coarctation of aorta             Inguinal hernia                                                                                                   ID Intractable epilepsy Hemiparesis (peri-ventricular leukomalacia)    
  31\.                                                                                                                               Central blindness Nystagmus                                                                                                                                                                                                                                                                                                                   ID Intractable epilepsy Hypotonia Distal spasticity                    
  32\.         Short stature                                                                                                                                                                                                                                                                                                                                                                                                                                                       Normal development                                                    Vomiting Feeding difficulties
  33\.                                                               Neck fistula                                                                                                                                                                   Dysmorphic malocclusion of teeth                                            Uni-ventricular heart                                                                                                                              Brain atrophy Epilepsy                                                Simian-crease Sinus pilonidalis
  34\.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ID Intractable epilepsy Hypotonia Distal spasticity                    
  35\.                                                               Dolicocephaly                                                   Epichantic fold                                                         Simple ears                            Thin upper-lip Long philtrum Broad nasal bridge                                                                                                                                                                                ID Arnold Chiari malformation                                          

The table presents the clinical characteristics of the 35 patients studied. DD = developmental delay, ID = intellectual disability.

SNP array
---------

DNA was extracted from blood samples according to standard protocols. Analysis by the Genome-wide human SNP array 6.0 was performed according to manufacturer protocols (Affymetrix, Santa Clara, CA, USA). In short; DNA was digested, ligated to adapters, and amplified by PCR. Samples were purified using magnetic beads and further fragmented and labelled with biotin. After hybridization arrays were washed and stained with streptavidin and anti-streptavidin antibodies and finally the arrays were scanned using the Affymetrix GeneChip scanner.

Analysis
--------

Data was extracted from the scanned image using the Genotyping console software V.3.0.2, creating a CEL file. Areas containing CNVs and allelic homozygosity were detected using the Hidden-Markow-Model. The resulting data was analyzed using the Chromosome Analysis Suite software V.1.0.

Reference data
--------------

Data was extracted by comparison to a reference data set established from 90 Caucasian individuals, which had previously been analyzed using the SNP 6.0 array in the HapMap project (<http://www.hapmap.org>). As an additional in-house reference set, we used results of 54 individuals studied using the SNP 6.0 array, whereof 19 healthy normal relatives of the patients, and 35 unrelated patients with an unexplained developmental disorder. Sample identities were kept anonymous and the information was only used for reference purposes. These in-house reference sets were used to filter out polymorphic changes in the patient data studied here.

Selected CNVs of the patients were compared to a Finnish population cohort \[[@B6]\]. This population cohort data consist of CNVs detected, using whole-genome SNP analysis, in 2163 healthy Finnish individuals with PennCNV \[[@B7]\]. In the population data, low quality samples (N = 98) with Log R Ratio standard deviation of probe signal intensities \> 0.35 or \> 115 CNV calls were excluded. Only CNVs with three or more probes were included in the final population data. CNV calls of the study samples were clustered into CNV regions when individual CNVs overlapped by one or more base pairs.

Filtering relevant CNVs and potential UPDs
------------------------------------------

The first set of default filtering marked all duplications and deletions ≥0.7Kb and all allelic homozygosities ≥100Kb containing at least 10 markers to be included. This was based on the theoretical resolution of the array being 0.7Kb, in addition to information from the HapMap phase 1 study showing that approximately 70% of common haplotype blocks are ≤100Kb \[[@B8]\] . Allelic homozygosity was called by the analysis software where there was a stretch of homozygous SNPs in a chromosomal segment.

The second filtering was based on the comparison of all aberrations detected in the patients of this study (N = 35), an in-house patient reference set (N = 35) and an in-house normal reference set (N = 19) as well as the database of genomic variants (DGV) \[[@B9]\]. Aberrations of one patient that were not present in any of the other groups (potentially "unique") were further processed by studying their genetic content and association to diseases and traits, as stated in publications or OMIM, and whether these correlated to the patient's phenotype. If this did not yield a candidate aberration, all aberrations of a patient were reviewed based on only the associated OMIM disease, despite the frequency of similar changes in the reference sets. The CNVs that were picked out as potential candidates were further compared to CNV data from 2,065 healthy Finnish individuals. Only those aberrations that were present in less than 50 individuals of the Finnish population cohort were initially considered as potentially pathogenic.

Validation of candidate aberrations
-----------------------------------

Only aberrations that were considered to potentially associate with patient's phenotype were attempted validation.

Microsatellite marker analysis
------------------------------

Potential segmental UPDs were analyzed by microsatellite marker analysis (chr15: D15S204, D15S124; chr6: D6S468, D6S2418; chr11: D11S4140; chr17: D17S578, D17S1832, D17S1828).

The markers were selected based on their location, and on information that they are highly polymorphic in the Caucasian population. Fragments were labelled with a fluorescent HEX label, and separated on an Applied Biosystem 3730XL (Life Technologies, Carlsbad, CA, USA) capillary electrophoresis instrument, according to manufacturer recommendations. Genotypes were called using Applied Biosystems GeneMapper 3.7 software.

Results
=======

The immense amount of data created by the Genome-wide human SNP array 6.0 warrants filtering for clear interpretation. The Genotyping Console software identified between 200--1000 changes per patient (Figure [1](#F1){ref-type="fig"}), depending on the technical quality of the result. More changes were detected in samples with lesser quality. After filtering, based on the uniqueness of the CNVs or regions of homozygosity compared to the references, each patient presented 8--20 unique changes (≥90% CNVs) on average. In samples with lesser quality, ≥100 unique changes were detected. Further research on gene content and phenotypes previously mapped to these regions revealed 23 CNVs and 28 regions of homozygosity that putatively correlated with the clinical phenotype in 26 patients. Nine patients had no CNVs or regions of homozygosity spanning known genes or genes known to associate with a disease that correlated with the patient's phenotype, and their results were thus considered normal. The associated phenotypes related to the aberration found in 26 patients were further evaluated by the patients' clinicians, and the frequencies of the observed CNVs were monitored in the Finnish population cohort (n = 2,065). As a result, in four patients, a region of allelic homozygosity was considered a potential candidate for causation of their clinical state (Table [2](#T2){ref-type="table"}). No CNVs were considered candidates after clinical evaluation.

![**Frequency of CNVs and allelic homozygosity.**The figure visualizes the frequency of copy number changes (loss and gain) and regions of allelic homozygosity (LOH) in 70 patients (patients of this study N = 35 and the in-house reference set N = 35) with developmental disorders of unknown cause as seen by the Integrative Genomics Viewer (IGV) software V.1.5 (The Broad Institute, Cambridge, MA, USA). The vertical bars show the percentage of patients that have a CNV in a particular area of a chromsome. The higher the bar, the higher the percentage, thus indicating as CNP.](1471-2350-13-84-1){#F1}

###### 

Results from microsatellite marker analysis

  **Patient**   **Chromosome location**   **Marker**   **Location start**   **Location stop**   **Patient**   **Mother**   **Father**        **Associated OMIMdisease(*gene*)**
  ------------- ------------------------- ------------ -------------------- ------------------- ------------- ------------ ----------------- -----------------------------------------------------------
  1             15q23q24.1                D15S204      72300758             72300879            123/123       123/125      123/125           MIM \#209900, Bardet-Biedl Syndrome (*BBS4*)
                                          D15S124      73092468             73092572            104/106       106/106      104/106            
  17            6q16.3                    D6S468       101630330            101630479           155/159       159/159      155/155           MIM \#611092, Mental retardation (*GRIK2*)
                                          D6S2418      101352425            101352639           222/230       222/248      230/238            
  32            11q13.4                   DS11S4140    71945684             71945874            195/195       195/197      195/197           MIM \#270400, Smith-Lemli-Opitz syndrome (*DHCR7*)
  28            17p13.2p13.1              D17S578      6824007              6824153             173/173       173/173      155/173           MIM \#201475, AcylCoA dehydrogenase deficiency (*ACADVL*)
                                          D17S1832     5972677              5972867             173/185       173/185      171/173/185/193    
                                          D17S1828     3810467              3810673             220/220       214/220      214/220            

The table presents the results of microsatellite marker analysis of 4 patients and their parents, suggesting biparental inheritance of the genomic segment, and thus exclude segmental UPD. The numbers in the patient/mother/father column represent the two markers detected. In all cases, the patient has likely inherited one marker from each parent.

We further attempted verification of four potential segmental UPDs by microsatellite marker analysis. In all the four cases we observed two distinct alleles with at least some of the more informative multiallelic markers, suggesting that the observed LOHs were most probably caused by the same allelic SNP haplotypes being inherited from both the parents (Table [2](#T2){ref-type="table"}).

Further comparison, of all patient SNP array data to the normal data from unaffected individuals, revealed 21 regions of clustering (≥40 % frequency) of allelic homozygosity to specific locations of the genome (Table [3](#T3){ref-type="table"}). However, no significant differences were detected between the frequencies of clustered regions in patients and the unaffected relatives in this small set of samples.

###### 

Regions of clustered allelic homozygosity

  **Chromosome**   **Band**        **Appoximate range (Kb)**   **Frequency patients (n = 70)**   **Frequency normals (n = 19)**
  ---------------- --------------- --------------------------- --------------------------------- --------------------------------
  **1**            p33-p32.3       48 700--53 300              47.7%                             47.7%
  **1**            q21.1-q21.2     145 800--148 500            49%                               50%
  **2**            q21.2-q21.3     134 334--136 693            42%                               58%
  **3**            p21.31-p21.1    46 500--52 500              71%                               68%
  **4**            p15.1           31 838--34 524              60%                               57%
  **8**            q22.2           99 200--101 200             47%                               63%
  **8**            p11.21-p11.1    41 870--43 270              49%                               47%
  **8**            q11.1-q11.21    47 040--49 000              46%                               68%
  **10**           p11.21          36 720--38 490              43%                               31%
  **10**           q22.2-q22.2     73 200--76 460              44%                               31%
  **12**           q21.32-q21.33   85 850--89 100              47%                               47%
  **12**           q24.11-q24.13   108 600--111 600            55%                               68%
  **14**           q23.3-q24.1     65 500--67 100              62%                               73%
  **15**           q12-q13.1       25 400--27 200              71%                               68%
  **15**           q15.1-q21.1     40 100--43 730              64%                               84%
  **15**           q23-q24.1       69 300--71 700              41%                               15%
  **16**           p11.2-p11.1     33 394--34 550              62%                               68%
  **16**           q11.2-q12.1     45 092--47 450              64%                               63%
  **16**           q21-q22.1       64 850--67 100              48%                               57%
  **17**           q22-q23.2       54 610--56 850              67%                               68%
  **20**           q11.22-q11.23   31 910--35 500              68%                               42%

The table presents the frequency (\> 40%) of clustered regions of allelic homozygosity in the patient cohort (n = 70, including in-house reference) compared to the unaffected relatives (n = 19). Kilobase range according to Genome build 19 (NCBI 37).

Discussion
==========

In our previous study of 150 patients with developmental disorders of unknown cause and a normal karyotype, we were able to identify a (potential) causative aberration in 18% of the patients, by using a 44 K or 244 K array CGH platform \[[@B2]\].

To determine whether, by increasing the resolution, any additional copy number changes or regions of UPD could be detected, we studied 35 patients with a normal array CGH result.

Allelic homozygosity is typically caused by linkage and co-segregation of certain blocks of DNA, termed haplotypes \[[@B8]\]. In a small founder population, such as the Finnish population, the founder effect increases the likelihood that the parents will have the same haplotype, and is as such not a segmental UPD \[[@B10]\]. True segmental UPD is typically due to a duplication in one chromosome and a reciprocal deletion in the other; or the fertilization of a disomic and monosomic gamete, somatic crossing over and subsequent trisomic rescue \[[@B11]\]. If the genomic segment harbours a recessive mutation, which subsequent to UPD will be present in two copies (reduction to homozygosity), it causes a recessive disease. Equally relevant, the segment can be preferentially imprinted, causing complete silencing, which is the equivalent of a deletion. Such presentations of recessive syndromes that are inherited from one normal parent are known in some 40 patients \[[@B12]\].

We were interested to see whether the regions of allelic homozygosity detected by the SNP array were in fact segmental UPDs and associated with an autosomal recessive disease. We were, however, unable to confirm these results and thus the SNP array did not yield more molecular diagnoses in this study of developmental disorders of unknown cause. This may be due to the fact that all patients had previously been studied by another high-resolution array, with 8.9Kb (244 K), 13Kb (180 K), and 35Kb (44 K) theoretical resolutions. Although several new CNVs, previously undetected by the array CGH platform, as well as regions of homozygosity were detected, the pathogenic relevance of these changes were considered insignificant in correlation to the patient's phenotype. It is, however, possible that changes dismissed in this study are pathogenic by means of spanning genomic segments that do not directly involve disease genes, but rather their regulatory elements.

Our results differ from previously published studies using similar research settings. Bernardini et al. (2010), using the SNP 6.0 array platform with a 75Kb cut-off value for detected CNVs, reported potentially pathogenic CNVs in 6% of patients with normal array CGH result (44 K) \[[@B13]\]. Mannik et al. (2010), using another SNP array with a 50Kb resolution, reported a 23% detection rate in patients with a normal karyotype \[[@B14]\]. Bernardini et al. and Mannik et al. had higher detection rates than this study; perhaps as their first-line of array analysis was, at least partly, done by a lower-resolution method (35Kb and 50Kb respectively) compared to the first-line of detection in this study (8,9Kb, 13Kb and 35Kb). Also, it is important to note that the statistical power is limited by the small size of our patient cohort, and thus results are not entirely comparable with Bernardini and Mannik's.

UPDs have not been reported in either of the above mentioned studies. However, in a study of 117 patients with a normal karyotype analysed using the 250 K SNP array (Affymetrix, Santa Clara, CA, USA), pathogenic CNVs were detected in 18 patients, and potentially pathogenic segmental UPDs ≥5 Mb in 5, verified by microsatellite marker analysis \[[@B15]\]. The presence of UPDs was also evaluated in another study of 120 patients, using a 500 K SNP array platform \[[@B16]\]. In that study they were unable to verify UPD in any of 121 detected regions of homozygosity in 72 patients with developmental disorder of unknown cause. In addition, in a study of 100 patients with developmental disorder, using a 500 K SNP array, two patients were found to have UPD, the clinical significance of which remained unclear \[[@B17]\]. Thus, UPDs are detectable using SNP arrays, but their clinical significance is difficult to interpret.

Conclusions
===========

Although there is a clear added value of high-resolution arrays in various fields of genetics, it seems that there is a limit to how much the yield can be increased by increasing the theoretical resolution of the analysis platform. Despite the fact that the SNP array has increased probe spacing compared to the 44 K, 180 K, and 244 K array, and is able to detect more CNVs and regions of homozygosity, interpretation of the vast amount of data and pinpointing of pathogenic changes is difficult. One benefit of using a SNP based platform is the possibility to detect UPDs; however these are relatively rare findings.

This study had a limited number of patients, and so it can only be said that for this study group the optimal yield was conceived when using a resolution of approximately 9Kb \[[@B2]\]. Increasing the resolution beyond that did not confer more diagnoses. It must be emphasized, however, that a larger patient cohort needs to be studied in order to draw final conclusions on the added value of an ultra-high resolution array compared to others. Furthermore, as several reports have shown, some pathogenic aberrations span only a few exons and for detecting such small changes the sensitivity of the SNP 6.0 platform is adequate \[[@B18]\]. It is, however a challenge to filter results correctly and so for diagnostic purposes the choice of platform needs to be carefully considered. Patients with developmental disorders of unknown cause and normal array results may also harbour such small genomic changes (i.e. mutations and unbalanced rearrangements) that are difficult to interpret using microarrays and would require higher resolution methods, such as whole-exome sequencing. Interestingly, a recent study suggests that 80% of patients with a developmental disorder of unknown cause and normal array results can be diagnosed using whole-exome sequencing \[[@B19]\]. Only the future can tell.
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